NCT01796145Active, not recruiting
Fibroscan Study in HCC
A Study to Evaluate the Impact of Liver Stiffness on Treatment Outcome of Hepatocellular Carcinoma
Source: ClinicalTrials.gov · Last updated 17 Nov 2025
Brief summary (registry, in English)
In patients with HCC undergoing therapy 1. We aim to determine the prognostic significance of liver stiffness in patients with HCC 2. We aim to determine the rate and severity of complications of treatment and its association with liver stiffness in patients with HCC
- Status (registry)
- Active, not recruiting
- Study type
- Interventional
- Enrollment
- 207 (actual)
- First submitted
- 20 Feb 2013
- Start date
- Feb 2013
- Primary completion date
- Dec 2026
- Lead sponsor
- Chinese University of Hong Kong
- Diseases
- Liver and biliary tract cancer
- NCT number
- NCT01796145
What you commit to
- Study type: Interventional
- Participants enrolled: 207
- From Feb 2013 to the primary completion date, Dec 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- ECOG performance status \> 2
- Poorly controlled ascites
Who the study is looking for
- Clinical diagnosis of HCC
- Patients who are scheduled to undergo therapy, either TACE systemic therapy or surgery
- For TACE cohort, patients undergoing first cycle TACE are eligible.
- For systemic therapy cohort, patients undergoing first-line systemic therapy are eligible.
- For surgery cohort, patient undergoing surgery are eligible.
- Prior surgery or loco-ablative therapy (e.g. Radiofrequency ablation, microwave, percutaneous ethanol injection) is allowed
- Child's A to Child's C liver function
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Department of Clinical Oncology, Prince of Wales Hospital Coordinator of this site? Confirm its status | Hong Kong | Hong Kong SAR China | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.